Clinical Trial Update: Phase I, KM-819 in Healthy Subjects for Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase I trial update for KM-819 in healthy subjects exploring Parkinson's disease treatment; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• KM-819 (KM-819)

Snippet

Sponsor: Kainos Medicine Inc. | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED | Results posted: 2020-04-13